Teverelix

Tax included
Teverelix (EP 24332) is a GnRH antagonist. Teverelix binds competitively and reversibly to GnRH receptors, thereby suppressing the release of LH and FSH. Teverelix can be used in the research of prostatic hyperplasia, endometriosis, and prostate cancer.
MedChemExpress 
HY-105173

Data sheet

Size
Multiple sizes
Reactivity
GnRH Receptor; Histamine Receptor
Application
Metabolism-protein/nucleotide metabolism
CAS
151272-78-5